Generic drug of the therapeutic class: Dermatology
active ingredients: Isotretinoin, Erythromycin
30 g tube
Local treatment of acne of medium severity.
Dosage ANTIBIOTREX 0, 05 g / 2 g Gel Tube of 30 g
- Adult :
. Apply ANTIBIOTREX, gel in moderation over the whole area to be treated, once or twice a day, after cleansing the skin.
. In some cases, 6 to 8 weeks of treatment are necessary before optimal therapeutic efficacy can be observed.
. Patients should wash their hands after applying ANTIBIOTREX gel.
. The patient should avoid the application of ANTIBIOTREX gel in excessive amounts as the excess gel can reach the eyes, nose or other unintentionally treated areas. The patient should be warned that excessive application of ANTIBIOTREX will not give better or faster therapeutic results but may cause severe redness, scaling or uncomfortable skin sensation. In this case, the treatment should be interrupted for a few days.
- The child:
Not established in children before puberty, given the rarity of acne vulgaris in this population.
No specific recommendations since acne vulgaris is not present in the elderly.
- ANTIBIOTREX should not be used in patients with:
. a known hypersensitivity to one of the constituents of the gel,
. acute eczema of the face, rosacea and perioral dermatitis.
- ANTIBIOTREX gel is contraindicated during pregnancy and breastfeeding as well as in women planning a conception:
. Pregnancy: There are no safety data on the use of ANTIBIOTREX in pregnant women. Isotretinoin has been associated with risks of teratogenicity in humans if administered orally. ANTIBIOTREX gel is contraindicated in pregnant women and women planning a conception. The treatment must be interrupted for a duration of 1 cycle before the date of conception.
. lactation: the percutaneous absorption of isotretinoin contained in ANTIBIOTREX is negligible. However, in the absence of data on the excretion of isotretinoin in breast milk, ANTIBIOTREX should not be used during breastfeeding.
Antibiotrex side effects
- ANTIBIOTREX may cause tingling, burning or irritation, erythema or desquamation in the area of application. These local effects usually disappear when treatment is continued. In case of severe irritation, the treatment should be stopped temporarily and restarted at the end of the reaction. If irritation persists, treatment should be stopped. All these reactions usually disappear when the treatment is stopped. - Increased susceptibility to sunlight or other sources of UVB has been reported. - In rare cases, prolonged use of preparations containing erythromycin may cause gram-negative folliculitis. In this case, the product must be permanently stopped and the treatment must be continued with a product without antibiotic.
- Due to the presence of butylated hydroxytoluene, risk of eczema and irritation of the skin.
- Due to the presence of alcohol, frequent applications on the skin can cause irritation and dryness of the skin.